Waters Corp (WAT)
Sector: Technology
Industry: Laboratory Analytical Instruments
Country: United States
Exchange: NYSE
Market cap: $37.34B
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.
Latest financial period: July 4, 2026
Filed with the SEC: August 11, 2026
Estimated earnings date: November 3, 2026
Not currently ranked. Cannot calculate: FCF yield
Profit Not currently ranked
| | Jul 26 | Apr 26 | Dec 25 | Sep 25 |
|---|
| ROIC | 9.0% | 10.8% | 21.4% | 22.1% |
Growth Not currently ranked
Payout Not currently ranked
Safety Not currently ranked
Price Not currently ranked
